Citadel Advisors’s Pfenex Inc. PFNX Stock Holding History

Citadel Advisors’s Portfolio PFNX Stock Details PFNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,562	Closed	-$300K	–	11909
2020 Q3	$300K	Buy	+23,562	New	+$249K	﹤0.01%	8129
2020 Q2	–	Sell	-17,595	Closed	-$132K	–	10845
2020 Q1	$155K	Sell	17,595 -30,496	-63%	-$335K	﹤0.01%	8267
2019 Q4	$528K	Buy	+48,091	New	+$478K	﹤0.01%	6729
2018 Q4	–	Sell	-19,109	Closed	-$98K	–	10082
2018 Q3	$98K	Buy	+19,109	New	+$98.2K	﹤0.01%	8587
2017 Q3	–	Sell	-16,338	Closed	-$66K	–	8294
2017 Q2	$66K	Buy	+16,338	New	+$75.2K	﹤0.01%	7026
2015 Q4	–	Sell	-10,229	Closed	-$154K	–	9414
2015 Q3	$154K	Sell	10,229 -44,153	-81%	-$897K	﹤0.01%	6483
2015 Q2	$1.05M	Buy	+54,382	New	+$912K	﹤0.01%	3904

Other funds holding PFNX

IRAG

Investment Research & Advisory Group Atlanta, Georgia $286M AUM 19.21% 1-Year Est. Return

Citadel Advisors's PFNX Position: Q4 2020 in Review

Citadel Advisors sold out of Pfenex Inc. (PFNX) in Q4 2020, closing a stake of 23,562 shares — an estimated $300K sold.

Citadel Advisors first reported a position in PFNX in Q2 2015 and held it in 7 quarters. The position peaked at $1.05M in Q2 2015. 1 fund tracked by Wall St. Rank holds PFNX as of Q4 2020.

Citadel Advisors reported no remaining Pfenex Inc. position as of Q4 2020 after selling out during the quarter.
Citadel Advisors sold 23,562 Pfenex Inc. shares in Q4 2020, an estimated $300K.
Citadel Advisors first reported a position in Pfenex Inc. in Q2 2015 and held it in 7 quarters.
Citadel Advisors's Pfenex Inc. position peaked at $1.05M in Q2 2015.
1 fund tracked by Wall St. Rank held Pfenex Inc. as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.